anti aging
Quality Rating
Buy Abaloparatide 3mg
PTHrP analogue — FDA-approved bone density agent for osteoporosis and skeletal strength
FDA-approved (Tymlos)86% vertebral fracture reductionMost potent bone anabolic
Who This Is For
Researchers studying bone formation anabolism, and users with osteoporosis or bone density concerns seeking the most potent bone-building peptide.
Overview & Benefits
Abaloparatide (trade name Tymlos) is FDA-approved for osteoporosis treatment in postmenopausal women at high fracture risk. As a PTHrP analogue, it binds the PTH1R receptor with preference for the RG conformation — selectively activating bone formation pathways with less bone resorption than teriparatide (PTH). The ACTIVE trial showed 86% reduction in vertebral fracture risk and 43% reduction in non-vertebral fractures. Among the most bone-anabolic compounds available.
Key Benefits
- FDA-approved bone anabolic agent
- 86% reduction in vertebral fracture risk in ACTIVE trial
- Selective PTH1R RG conformation preference — more bone formation, less resorption vs PTH
- Increases bone mineral density measurably within 6–12 months
- Once-daily subcutaneous injection
Protocols & Dosing
Once-Daily Bone Building
Once daily80mcg subcutaneous abdomen
Inject in abdominal area. Monitor for orthostatic hypotension initially. Run 18-month cycles as in FDA approval protocol.
Stack With These Peptides
Buy Abaloparatide 3mg
$149.99
Buy Now — $149.99Buy at PhiogenResearch-grade · COA verified · Phiogen
Categoryanti aging
Typeinjectable
Quality Rating★★★★★
VendorPhiogen
Abaloparatide 3mg
$149.99